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ABSTRACT 
Autoimmune diseases show high diversity in the affected organs, clinical 
manifestations and disease dynamics. Yet they all share common features, such as the 
ectopic germinal centers found in many affected tissues. Lineage trees depict the 
diversification, via somatic hypermutation (SHM), of immunoglobulin variable-
region (IGV) genes. We previously developed an algorithm for quantifying the 
graphical properties of IGV gene lineage trees, allowing evaluation of the dynamical 
interplay between SHM and antigen-driven selection in different lymphoid tissues, 
species, and disease situations. Here, we apply this method to ectopic GC B cell 
clones from patients with Myasthenia Gravis, Rheumatoid Arthritis, and Sjögren’s 
Syndrome, using data scaling to minimize the effects of the large variability due to 
methodological differences between groups. Autoimmune trees were found to be 
significantly larger relative to normal controls. In contrast, comparison of the 
measurements for tree branching indicated that similar selection pressure operates on 
autoimmune and normal control clones. 
 
Keywords: germinal centers, somatic hypermutation, Myasthenia Gravis (MG), 
Rheumatoid Arthritis (RA), Sjögren’s Syndrome (SS).  
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1 INTRODUCTION  
Germinal Centers (GCs) in primary lymphoid follicles are where rapid B cell 
proliferation, differentiation, somatic hypermutation (SHM) of immunoglobulin 
variable region (IGV) genes, and antigen-driven selection, lead to the preferential 
survival of those B cells with high affinity receptors to the antigen. Mutational lineage 
trees, depicting clonal relationships between related cells within a lineage, have 
frequently been drawn to illustrate IGV gene diversification in GC B cell clones 
derived from a few founder B cells. The qualitative features of IGV lineage trees have 
been used to interpret the dynamics of the GC response [1-2]. However, qualitative 
observations are limited to only the most obvious tree shape characteristics, and can 
only be used to compare a small number of trees at one time. Hence, we developed a 
rigorous computer-aided algorithm for the measurement of graphical shape properties 
of lineage trees, MTree© [3]. This method enables a more extensive investigation of 
the dynamics of the GC response. Previous studies have demonstrated the usefulness 
of this method, and resulted in new insights of various aspects of the GC reaction in 
normal situations [3-4], ageing [5-6], B cell malignancies [7,8], and chronic viral 
diseases (Margolin et al, submitted). In the present study, the GCs of individuals with 
autoimmune (AI) diseases are studied using lineage tree analysis. 
The general cause and trigger of most AI diseases is unknown. Most AI disease 
studies focus on the role of T cells in the initiation of inflammation, whereas the 
production of pathogenic auto-antibodies by B cells is often overlooked [9]. 
Nevertheless, in many autoimmune diseases, ectopic GC-like areas develop within the 
afflicted tissue or organ, where AI B cells do undergo SHM and antigen mediated 
selection [10-14]. Hence, understanding the nature of ectopic GC B cell selection may 
yield new insights into the development of these diseases.  
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We created mutational lineage trees based on published IGV sequences from 
ectopic GC or affected tissue B cell clones in patients with Myasthenia Gravis (MG), 
Rheumatoid Arthritis (RA), Sjögren’s Syndrome (SS), and Multiple Sclerosis (MS). 
These IGV lineage trees were analyzed using our MTree© program and compared to 
IGV trees from normal human samples. We observed a high variability between the 
different data sets [15] due to the data having been generated by different research 
groups at different times, using several methods to extract DNA sequences from 
samples of patients in which disease duration and severity probably varied as well. 
Moreover, the methods of tree generation from sequence alignments differed for some 
data sets. In the present study, we used a number of scaling techniques to alleviate the 
effects of experimental inconsistencies between research groups. Although the effects 
of the varying experimental methods were not completely neutralized, our analysis 
reveals that AI disease lineage trees are larger than their normal counterparts, likely as 
a result of the chronic nature of AI disease. Surprisingly, however, the selection 
process of the AI germinal center remains similar to that of the normal GC. 
 
2 MATERIALS AND METHODS 
2.1 Sources of sequences and database of IGV and tree data  
A thorough literature and GenBank search yielded IGV sequences from patients with 
AI diseases. IGV sequences, lineage trees we created, and all tree measurements were 
stored in a database created specifically for lineage tree data storage and analysis, using 
a Microsoft SQL server (http://www.microsoft.com/sql/default.mspx), with a user-
friendly Microsoft Access interface. Database tables store the administrative data of the 
experimental groups, the patients and the diseases, along with IGV sequences, the trees 
themselves and the resulting tree measurements. The tables are set up hierarchically, 
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using unique identification keys so that data in different tables can be connected and 
obtained through queries (Supplementary Figure 1), and allow for a convenient 
connection with statistical application programs.  
 
2.2 Lineage tree generation and measurements 
Some of the studies we found [10,12,14] contained lineage trees but no published 
sequences. In others, only sequences were published [16-21]; in these cases, germline 
genes were identified by alignment with published human IGV using DNAPLOT 
(http://vbase.mrc-cpe.cam.ac.uk/), and accordingly grouped and aligned using 
ClustalW (http://www.ebi.ac.uk/clustalw/). Trees were then generated using our 
program IgTree© (M. Barak et al, in preparation), which is specifically tailored to 
deal with IGV sequences. Lineage tree shape properties were quantified as described 
[15] by our MTree© program (Supplementary Figure 2, Supplementary Table 1).  
 
2.3 Scaling 
Tree properties were scaled by either the sequence alignment length (S), or by pick 
size – the total number of sequences, defined as either the "Tree" pick size (the 
number of sequences used per tree, not including the root sequence, but may have 
included identical sequences); or the "Lab group" pick size, i.e., the total number of 
sequences available in the study group that could be used to generate the trees.  
 
2.4 Statistical analysis 
GC simulation results (Shahaf et al. in preparation) show that lineage tree properties 
are not normally distributed. Hence we used the Mann-Whitney nonparametric test for 
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independent samples, and the Wilcoxon test for related samples. Multiple comparison 
correction (as we measured 25 different tree properties) was done by the FDR method 
[22], thus the minimal α=0.05/25=0.002. FDR correction was performed separately 
for the unscaled and scaled data as they were compared independently of each other. 
Only differences that remained significant after FDR correction were considered as 
meaningful.  
 
2.5 R:S Analysis 
Replacement and silent mutations were enumerated and statistically analyzed with a 
computer program developed in our Lab (Zuckerman et al., unpublished) using the 
Lossos et al. multinomial correction [23] to the Chang & Casali method [24].  
 
3 RESULTS 
3.1 Large variability of AI data sets and the necessity for data scaling  
Mutational lineage trees of B cell clones from patients with MG, RA, SS, and MS 
[6,16-21], and from normal human GCs [25-26], were created from published and 
unpublished IgV sequence data; we also used published lineage trees [12,10,14]. Each 
dataset contained IGV sequences from different IGV groups and patients (Table 1). 
Where lineage tree measurements of different groups within a dataset did not 
significantly differ, such groups were combined [15]. Sample trees are shown in 
Figure 1.  
Tree measurements of AI data sets were compared to those of trees from normal 
human samples of both Peripheral blood lymphocytes (PBL [8]) and germinal centers 
(GC [6,26]), revealing large variability between the data of the different groups, 
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including between data sets of the same disease (Figure 2). Despite this variability, in 
all but two sets [10,14] the trees were larger than in the normal control data sets, 
whether we look at the number of leaves L, i.e. end cells in the sample (Figure 2A), 
the total number of mutations per clone, N (Figure 2B), or the maximum path length 
from root to leaf, PLmax (Figure 2C). This suggests a more vigorous diversification 
process in the ectopic AI GCs than in the normal controls.  
The differences found between the L, N, and PL of the different AI datasets are 
most likely due to small methodological differences at all stages of data extraction 
(sampling, cell labeling, and DNA amplification), the source of tissue sample and the 
duration of the disease at time of sequence extraction. Moreover, tree generation 
methods may differ between data sets as some trees [10,12,14] were taken from 
published data where IGV sequences were not available. Two AI datasets [10,14] had 
smaller N and PL measures than those of the normal controls, probably also due to 
methodological differences in Ig sequence extraction and tree generation, as both 
these data groups come from the same lab.  
In order to distinguish between methodological and actual differences, data were 
scaled by pick sizes or sequence alignment lengths. The sequence alignment length 
directly affects the number of nodes in a tree: the longer an alignment length, the 
greater the chances of finding mutations, hence longer alignments give large N and 
PL, amongst other outcomes. Thus N, PL, and partial paths on the tree (such as T, 
DASN or DLSN) may be scaled by sequence alignment length, to reduce the effects 
of sequence length differences, The pick size – the number of actual sequences which 
were sampled and are included in the tree – directly affects the number of leaves, 
which in turn affects the tree size N, and the degree of tree branching, as measured by 
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OD. Therefore, we scaled the N or OD measurements by either the "Tree pick size", 
or the "Lab group pick size", as defined above.  
A comparison of the average sequence alignment lengths (Figure 3C) between data 
sets showed some variability, although slight, relative to that of AI datasets in the tree 
size measurements. On the other hand, the variability of the lab pick size and tree pick 
size (Figure 3 A and B) of the different AI data sets seemed to reflect the variability 
seen in the unscaled tree measurements. 
 
3.2 Scaling confirms larger diversification in AI lineage trees 
All measurements were scaled by the sequence alignment lengths and then the rates of 
mutation per division, as measured by the PL, or the related measure DLFSN, were 
compared (Figure 4). Although variability between the AI data sets persisted, most of 
their PL and DLFSN measurements remained significantly larger than those of the 
normal controls, supporting the hypothesis of a more vigorous diversification process 
in the AI germinal centers.  
 
3.3 B cell selection in AI GCs is normal 
While trees from AI diseases have longer paths, representing a longer diversification 
process, this may or may not indicate changes in B cell selection. The degree of tree 
branching, measured as the number of outgoing branches per node or outgoing degree 
(OD), indicates the extent of selection pressure, based on the assumption that 
selection will kill cells and thus reduce the number of leaves and hence of branches 
[4]. Unscaled OD measurements did not vary greatly between all different AI data 
sets, (not shown). Nonetheless, the experimental variability likely influenced OD 
measurements as well, hence they were scaled by tree pick size (number of sequences 
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sampled to create the tree), as the more sequences that are available to build a tree, the 
higher the likelihood of an increase in tree branching. A comparison of the scaled OD 
measurements (Figure 5) revealed that, in spite of the variability between AI data 
groups, the values remained of similar magnitude or smaller than those of normal 
controls. This suggested a trend of normal tree branching and correspondingly, a 
normal selection strength acting on the B cells in the ectopic germinal centers.  
Similarly, the distances between adjacent split nodes (DASN), and the distances 
from a leaf to the last (or closest to the leaf) split node (DLSN), which are shorter in 
more branched trees and hence directly reflect selection strength, were scaled by 
sequence alignment length (Figure 6). The scaled DASN and DLSN, although slightly 
less variable than their unscaled values, were still mostly as large as those of control 
tissues, confirming the hypothesis of normal selection pressure.  
As an additional verification, we performed R:S mutation analysis [23-29] on our 
data, showing that the AI clones underwent positive antigen-mediated selection, at 
least as strong as that in normal clones (Supplementary Table 3). R:S analysis is 
known to give many false positive indications of selection [30-31]. Nonetheless, it 
may be used to validate the existence of selection in cases where it has already been 
suggested by our lineage analysis, though it cannot be used to refute our findings in 
cases where we found no selection.  
 
3.4 MS data from two time points 
Sequences obtained from two MS patients [20] were taken at two points in time each: 
Patient 1 was sampled at disease onset  (time 0) and 1 year later (time 1); Patient 2 
was sampled 9 years (time 0) and 13 years (time 1) after initial Diagnosis. Sequences 
from the two time points were compared in [20] for each patient using oligoclonal 
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patterns, heavy chain CDR3 lengths – which are a measure of repertoire diversity in 
normal populations – and frequencies of VH families used. The study concluded that 
a more active diversification pattern occurred in the initial stages of the disease 
followed by a persistence of "memory" clones that were selected for their antigenic 
specificities.  
 In order to better understand the diversification and selection pressures which occur 
over time in MS, we created IGV lineage trees from published sequences [20]. The 
tree measurements of those clones from the same patient that appeared in both time 
points were compared to each other, and a paired Wilcoxon test was performed. 
Because only four clones from both time points were available for each patient, tests 
lacked statistical significance. Nevertheless interesting trends were observed. although 
the number of accumulated mutations per cell, as measured by PL, increased from the 
first time point to the second in both patients, as would be expected if the same clones 
continued to develop with time, the degree of tree branching, represented by the 
maximum OD value (Figure 7), remained similar. Thus, in contrast to the conclusion 
of [20], our analysis suggests similar diversification patterns at both time points for 
both patients. Moreover, an increase in selection pressure in patient one and a 
decrease in patient two was shown by the DASN and DLSN measurements (Figure 7). 
The consequences which led to the observed changes are unknown, and more clones 
and time points would be necessary to make clear conclusions as to the nature of the 
B cells in the ectopic germinal centers of MS patients.  
 
4 DISCUSSION  
The present study aimed to investigate the ontogeny and progress of AI diseases, 
using lineage tree analysis of Ig sequences. To reduce the variability caused by 
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methodological differences between experimental groups, data were scaled by pick 
size or sequence alignment length. The results depicted the larger sizes of AI trees 
relative to the normal controls, indicating more mutations accumulated and a more 
vigorous diversification process, as expected due to the chronic nature of AI diseases. 
Even more notable was the unexpected discovery that selection acting on AI disease 
cells was no different from that in controls, despite the irregular locations of ectopic 
GCs. This conclusion is significant because, while the oligoclonal nature of the 
sequences in the germinal center was apparent from the experimental studies from 
which data were extracted, the extent of selection, if any, was unclear. In this context 
it is noteworthy that follicular dendritic cells have been identified in ectopic GCs in 
RA [32], SS [10], and MG [12] and their presence supports the evidence for antigen-
driven selection. 
The study by Colombo et al., [20], where Ig sequences were extracted from MS 
patients at two time points in the course of their disease, concluded that a more active 
diversification pattern occurs in the initial stages of the disease. The analysis 
presented here does not support this conclusion, as diversification shown by the PL 
measures continues at a similar pace. Moreover, the selection pressures in both cases 
seem to operate similarly on the clones. 
Lineage tree analysis thus has the potential of yielding new findings concerning 
ectopic GCs in MS and other AI diseases. In order to successfully do so, in future 
studies larger Ig sequence sampling, the sampling of more than two time points, and 
the study of more patients must be undertaken. Furthermore, studies in which 
sequences are extracted from a larger number of patients with the same disease 
undergoing different treatments, or varying in symptoms or response to treatment, at 
different time points, may lead to an understanding of the progression of the diseases 
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and the effects of their treatments. In most Ig sequence data available to date, only the 
V segment of the Ig gene is sequenced, and hence in this study only the V segments of 
the Ig sequences were aligned for tree generation. As a result, trees are smaller than 
they would have been had the whole IGV segment been used.  
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FIGURE LEGENDS 
Figure 1.  Sample tree figures created from B cell clones extracted from:  A. Normal 
Peyer's  patch [5];  B. Light chain B cell clones from the parotid gland of a SS patient 
[21];  C. Heavy chain B cell clones from a lymph node of a SS patient [19];  D. Heavy 
chain B cell clones from the CSF of an MS patient [16].  Double circles represent the 
germline (unmutated) root sequence; the dark circles are experimentally generated 
sequences, most of which are leaves; the dashed circles represent deduced 
intermediate sequences.  The numbers along the vertical lines represent the number of 
mutations unique to a sequence compared to the immediately preceding sequence.  
 
Figure 2 . Comparison of AI disease data to normal controls, unscaled: A) Number of 
leaves, L; B) Number of nodes, N; C) maximum path length, PLmax. Data sources 
are as in Table 1. Significant differences between AI datasets to normal GC control 
are labeled by ‘*’; Significant differences between AI datasets to normal PBL controls 
are labeled by ‘#’. P Values are given in Supplementary Table 2(A). Tree properties 
are as described in the text and in Supplementary Table 1.  
 
Figure 3. Comparison of all data sets for Lab group pick size (A), and Tree pick size 
(B) – both given in numbers of sequences; and sequence alignment length (C), given 
in number of nucleotides (except for groups 1 and 5, for which we do not have the 
sequence alignment lengths). Data sources are as in Figure 2. Tree properties are as 
described in the text and in Supplementary Table 1.  
 
Figure 4. Comparison of maximum PL (white) and DLFSN (striped) measures of AI 
data sets to normal controls, scaled by the sequence alignment length (minimum and 
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average measures reveal similar trends). Data sources and significance markers are as 
in Figure 2; P Values are given in Supplementary Table 2(B). Tree properties are as 
described in the text and in Supplementary Table 1.  
 
Figure 5 Comparison of maximum L (gray) and maximum OD (striped) measures of 
AI data sets compared to normal controls, scaled by the tree pick size (minimum and 
average OD measures reveal similar trends). Data sources and significance markers 
are as in Figure 2; P Values are given in Supplementary Table 2(C). Tree properties 
are as described in the text and in Supplementary Table 1.  
 
Figure 6. Comparison of maximum DASN (white) and DLSN (striped) measures, 
unscaled (top) and scaled by sequence alignment length (bottom), of the AI data sets 
to the normal controls. Data sources and significance markers are as in Figure 2; P 
Values are given in Supplementary Table 2(D,E). Tree properties are as described in 
the text and in Supplementary Table 1.   
 
Figure 7. Comparison between time point 1 (white) and 2 (striped) of tree 
measurements T, L, as well as maximum PL, OD, DASN and DLSN values (similar 
trends were found for average values of these measurements), from patient 1 (top) and 
patient 2 (bottom). Tree properties are as described in the text and in Supplementary 
Table 1.  
 
Supplementary Figure 1: The Hierarchical structure of the IGV lineage tree 
database. 
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Supplementary Fig 2  A sample Lineage tree (left) and the same lineage tree in text 
format as tree list (right). A lineage tree is defined, graphically, as a rooted tree where 
the nodes correspond to B cell receptor gene sequences. For two nodes X and Y, we 
say that Y is a child of X if the sequence corresponding to Y is a mutant of the 
sequence corresponding to X, which differs from X by only one mutation, and is one 
mutation further than X away from the original (germline) gene, that is, the root. Two 
B cells with identical receptor genes will thus correspond to the same node. A lineage 
tree depicts the maturation process of a B cell clone at a certain moment of 
observation – it consists only of the IG sequences of cells that were sampled at that 
moment and their ancestors back to the root, which were not necessarily sampled at 
the time of observation. Nodes in the tree can be either the root node, leaves (end-
point sequences), or internal nodes, which can be either split nodes (branching points) 
or pass-through nodes. The complete list of variables measured is given in 
Supplementary Table 1, including remarks on the meaning and usefulness of each 
variable. 
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 0      1 
 1      2     3    
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10 
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98 7 
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Table 1: Data sources 
 
Refa Disease / Tissue # of 
Patients
# of 
Trees
Methods Ig Chain 
1 MG / Thymus 1 13 MD HC 
2 RA / ST 2 12 MD HC 
3 RA / ST 2 4 MD HC, λLC, κLC 
4 RA / ST 2 14 SCS HC 
5 SS / LSG 2 4 MD HC, LC 
SS / LSG 10 
6 
SS / LN 
2 
7 
MD HC 
SS / PBL 12 κLC 
7, 8 
SS / PG 
1 
9 
SCS 
λLC, κLC 
MS / CSF 7 
9 
MS / PBL 
2 
3 
SCS HC 
Normal / LN 2 4 MD HC 
Normal / PP 7 10 
Normal / Spleen 
5 
12 
MD HC 
11 Normal / PBL 2 42 SCS LC 
 
1-Sims et al. 2001 [12], 2-Gause et al. 1995 [18], 3-Kim et al. 1999 [14], 4-Miura et 
al., 2003 [17], 5-Stott et al., 1998 [10], 6-Gellrich et al., 1999 [19], 7-PG data; Jacobi 
et al., 2002 [21], 8-PBL data; Jacobi et al., 2002[21], 9-Colombo et al., 2000 [16], 10-
Kuppers et al. [21], 1993, and Banerjee et al., 2002 [5], 11- Abraham et al. 2005[22]. 
Tissues : ST : Synovial tissue ; PG : Parotid Gland; LSG; Labial salivary glands; LN: 
Lymph nodes; PP: Peyer's Patch. Experimental methods: MD: Micro-dissection; 
SCS: Single cell suspensions. aAll trees were generated using our algorithm from 
sequence data, except those in Sims et al., 2001 [12], Stott et al., 1998 [10], and Kim 
et al., 1999 [14], in which only trees and not sequences were given.  
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Supplementary Table 1:  Tree measurements and their definitions 
 
Tree variable definition Abbreviation Range 
Total number of nodes, including the root. Indicates the 
overall tree size. 
N N ∈ [2, ∞) 
Total number of leaves, that is, the number of distinct 
sequences found, for which there were no "descendant" 
sequences. 
L L ∈ [1, N-1] 
Number of internal nodes, that is, nodes that are not 
root or leaves. 
IN IN ∈ [0, N-(L+1)] 
Number of pass-through nodes, that is, internal nodes 
that have only one child. 
PTN PTN ∈ [0, IN] 
Length of tree trunk from root to the first split node, 
that is, the number of mutations shared by all leaves. 
T T ∈ [0, N-1] 
Path length, where a path is defined from the root to a 
leaf, hence PL gives the number of mutations per leaf.b 
PLa PL ∈ [1, N-1] 
Distance from a leaf to the first (closest to root) split 
node: DLFSN(leaf i) =PL(leaf i)-T 
DLFSNa DLFSN ∈ [1, MaxPL] 
Outgoing degree, representing the number of children 
per split node.c  
ODa 
AvgOD, MinOD, and 
MaxOD  ∈ [1,L] 
AvgOD2 ∈ [2,L] 
The root’s outgoing degree, that is, the number of 
branches emerging from the root.  RootD=1⇔ T>0.  
RootD RootD ∈ [1,L] 
Distance between adjacent split nodes, that is, between DASNa DASN ∈ [1, N-(L+1)] 
 27 
two consecutive splits on the same path.d  
Distance from a leaf to the last (closest to leaf) split 
node.e  
DLSNa DLSN ∈ [1,N-1] 
Distance from the root to any split node. DRSNa DRSN ∈ [1, MaxPL] 
 
a. Minimum, Maximum and Average values measured 
b. Longer path lengths (in one group of trees relative to another) thus indicate that the 
cells are dividing more rapidly, and/or have a higher mutation rate (per division), 
and/or that the hypermutation process has been going on longer in these clones 
relative to those of the other group.    
c. Minimum and maximum OD are measured over split nodes, but if there are no 
splits (L=1) they both equal 1. AvgOD is measured over all nodes, including pass-
through nodes. AvgOD2 represents the outgoing degree averaged only over all split 
nodes.  
ODs are measured of a tree’s level of branching, or “bushiness”, which is 
interpreted as indicating the rate of diversification relative to the strength of the 
selection forces acting on the tree, as selection tends to “prune” the tree (by killing 
cells with disadvantageous mutations) and hence reduce its bushiness.  
d. It is an inverse measure of bushiness (or a direct measure of the relative strength of 
selection) over the whole tree, hence over the whole history of the clone.  
e. It is an inverse measure of bushiness (or a direct measure of the relative strength of 
selection) over the recent history of the clone. 
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Supplementary Table 3:  R:S analysisa 
 
Data 
Set 
# of 
Sequences 
Checked 
Pval Sig in 
FR 
Pval Sig in 
CDR 
R/S <2.9 in 
FR 
R/S>=2.
9 in 
CDR 
2 40 12/40 12/40 29/40 20/40 
  3.00E-01 3.00E-01 7.25E-01 5.00E-01
4 191 143/191 94/191 179/191 90/191 
  7.49E-01 4.92E-01 9.37E-01 4.71E-01
6 74 52/74 42/74 69/74 39/74 
  7.03E-01 5.68E-01 9.32E-01 5.27E-01
7 72 34/72 29/72 64/72 30/72 
  4.72E-01 4.03E-01 8.89E-01 4.17E-01
8 63 20/63 15/63 60/63 18/63 
  3.17E-01 2.38E-01 9.52E-01 2.86E-01
9 101 67/101 55/101 76/101 47/101 
  6.63E-01 5.45E-01 7.52E-01 4.65E-01
DDW 129 11/129 18/129 93/129 52/129 
  8.53E-02 1.40E-01 7.21E-01 4.03E-01
 
aA comparison of the results between the different AI datasets to the normal controls 
supported the results already shown by the OD tree measurements from our study.  
The analysis showed (third column) that the number of IGV sequences in each of the 
corresponding AI datasets had statistically significant differences (p< 0.05) from the 
random diversification frequencies of R and S mutations in the FR.  All AI datasets 
were found to have higher fractions than those in the normal datasets analyzed, 
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indicating that selection occurred in at least some of the AI clones.  Similarly, the AI 
dataset clones had larger fractions of statistically significant differences (p< 0.05) 
from the random diversification frequencies of R and S mutations in the CDR than the 
normal control datasets' clones (fourth column).  Again, this indicated that the AI 
clones analyzed had undergone selection.   
The R:S mutation ratio expected under a random process based on the inherent 
mutability of all codons and their frequencies is 2.9; hence an R:S ratio less than 2.9 
in the FR and at least 2.9 in the CDR is believed to represent positive antigen 
mediated selection of the B cell clones analyzedb.  The fraction of sequences to have 
an R:S ratio less than 2.9 (or in the case where S=0, R is less than 2.9)  in the FR is 
shown in the fifth column.  The results indicated that all of the AI datasets had the 
same or higher fractions of clones with an R:S ratio less than 2.9 in the FR.  The sixth 
column which contains the fractions of clones with an R:S ration more, or equal to 2.9 
(or in the case where S=0, R is at least 2.9) in the CDR, resulted in similar indications.  
All AI datasets had higher fractions of clones with an R:S ratio equal or above the 
random ration of 2.9.  Hence, it was apparent that the AI clones underwent positive 
antigen-mediated selection, at least as strong as that  
in normal clones, which supported our previous findings using tree measurement data. 
bJukes T.H., and King J.L. 1979. Evolutionary nucleotide replacements in DNA. Nature 281: 
605-606.  
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Supplementary Table 2: P-values from comparisons of tree properties 
 
AI Datasets 1 2 3 4 5 6 7 8 9  
Control sets 10 11 10 11 10 11 10 11 10 11 10 11 10 11 10 11 10 11 
L 3.97E-01 7.96E-05 2.12E-02 7.33E-02 8.69E-01 3.73E-02 4.74E-06 1.60E-07 4.89E-01 7.76E-03 6.85E-01 3.04E-04 4.83E-01   2.07E-03   5.50E-01 9.58E-04 
N 2.81E-01 1.20E-01 7.91E-02 3.31E-02 6.69E-01 8.45E-01 8.66E-10 7.83E-08 1.00E+00 6.82E-01 8.41E-09 2.63E-07 6.00E-04   5.88E-01   6.48E-07 2.90E-05 
 
 
A PLmax 8.69E-02 8.64E-02 2.12E-02 9.78E-02 7.18E-01 4.35E-01 8.66E-10 6.84E-07 7.18E-01 8.61E-01 1.58E-10 2.86E-07 2.57E-03   3.70E-01   2.10E-06 2.76E-04 
PLmin NA NA 6.02E-01 5.28E-01 1.00E+00 5.68E-01 6.81E-02 3.88E-01 NA NA 1.54E-06 1.99E-03 2.12E-01 9.56E-02 9.56E-04 3.35E-04 6.86E-06 1.41E-02 
PLmax NA NA 4.99E-03 1.05E-01 6.52E-01 1.70E-01 9.70E-09 3.68E-06 NA NA 4.41E-10 8.96E-07 1.54E-03 5.19E-02 8.84E-01 1.99E-01 2.12E-05 5.55E-03 
PLav NA NA 1.50E-02 3.28E-01 7.12E-01 2.10E-01 3.88E-08 2.02E-04 NA NA 8.82E-10 3.87E-06 8.89E-03 5.05E-01 1.04E-01 8.07E-03 1.48E-05 5.17E-03 
DLFSNmin NA NA 5.18E-01 2.11E-01 9.82E-02 3.72E-01 1.04E-03 1.48E-03 NA NA 7.03E-07 1.28E-05 7.43E-01 5.09E-01 3.87E-01 9.85E-01 2.90E-06 1.23E-04 
DLFSNmax NA NA 5.78E-03 3.30E-01 6.59E-02 5.87E-02 9.70E-09 1.72E-05 NA NA 4.41E-10 5.22E-06 6.25E-03 1.33E-01 1.73E-01 9.27E-01 4.10E-05 2.31E-02 
 
 
 
 
B 
DLFSNav NA NA 1.16E-02 1.35E-01 8.07E-02 5.87E-02 9.70E-09 1.48E-05 NA NA 4.41E-10 7.87E-07 1.45E-01 5.20E-03 6.11E-01 4.96E-01 2.12E-05 2.56E-03 
L (Leaves) 2.93E-01 4.72E-03 2.67E-01 4.18E-01 8.37E-01 6.99E-01 4.86E-03 5.87E-01 1.95E-01 9.84E-02 1.09E-03 3.60E-01 5.95E-02 4.17E-01 1.46E-01 3.55E-01 7.17E-02 5.93E-01 
ODmin 2.26E-01 1.18E-04 1.32E-02 5.35E-01 9.67E-01 2.40E-01 2.91E-04 2.59E-07 7.74E-01 4.23E-02 1.26E-01 3.83E-02 8.60E-01 2.11E-02 6.02E-01 1.28E-02 9.81E-01 2.43E-02 
ODmax 5.64E-02 5.66E-05 1.50E-02 5.96E-01 3.42E-01 3.26E-01 1.52E-05 2.16E-07 7.12E-01 4.23E-02 3.69E-01 2.19E-02 6.68E-01 2.77E-02 3.46E-01 5.89E-02 5.88E-01 1.63E-02 
ODavg 1.46E-01 1.88E-04 3.46E-02 6.67E-02 7.12E-01 1.47E-01 1.98E-05 6.04E-07 4.84E-01 1.45E-02 4.05E-01 8.59E-04 4.63E-01 5.72E-03 4.91E-01 2.37E-03 7.24E-01 2.05E-03 
 
 
 
 
C ODavg2 1.35E-01 6.74E-03 1.32E-02 9.84E-01 6.52E-01 5.92E-01 5.29E-05 2.26E-05 9.02E-01 2.62E-01 1.43E-01 2.68E-01 6.31E-01 1.25E-01 6.02E-01 1.69E-01 7.96E-01 1.10E-01 
DASNmax 1.23E-01 3.36E-01 6.48E-01 5.56E-01 7.05E-01 8.83E-01 2.93E-06 5.31E-04 6.69E-01 1.18E-01 1.02E-02 2.72E-02 7.06E-02     3.67E-01 2.15E-02 2.98E-02 
DASNav 1.00E-01 2.61E-01 7.05E-01 1.25E-03 4.42E-01 9.42E-01 1.21E-02 3.13E-02 6.69E-01 1.18E-01 8.20E-03 4.90E-02 3.56E-01     9.69E-01 6.90E-02 4.70E-01 
DLSNmax 6.03E-01 2.60E-01 5.68E-04 7.33E-02 2.43E-01 1.29E-02 8.66E-10 2.40E-05 2.75E-02 8.17E-03 2.25E-11 1.28E-05 1.54E-03     3.40E-01 1.45E-06 7.16E-03 
 
 
D 
 DLSNav 8.45E-01 2.02E-02 2.97E-04 2.51E-01 4.09E-01 1.63E-02 8.66E-10 6.91E-05 1.38E-02 4.15E-03 2.25E-11 4.93E-07 4.90E-04     1.32E-01 5.81E-06 2.23E-03 
DASNmax NA NA 8.87E-01 9.46E-01 9.62E-01 8.00E-01 4.18E-05 5.32E-04 NA NA 3.10E-02 2.74E-02 1.37E-01 2.10E-01 2.16E-01 4.46E-01 1.41E-01 5.19E-02 
DASNav NA NA 8.87E-01 7.36E-01 7.40E-01 1.00E+00 8.90E-02 1.91E-01 NA NA 7.70E-03 2.75E-02 6.73E-01 8.31E-01 5.67E-01 9.13E-01 2.97E-01 4.51E-01 
DLSNmax NA NA 1.37E-03 3.69E-01 6.59E-02 1.12E-02 9.70E-09 1.61E-04 NA NA 4.41E-10 1.49E-05 2.90E-03 3.72E-01 7.56E-02 2.75E-01 1.02E-05 3.12E-02 
 
 
 
E DLSNav NA NA 7.94E-04 8.51E-02 2.27E-01 8.38E-03 9.70E-09 2.44E-04 NA NA 4.41E-10 4.09E-07 1.23E-03 2.63E-01 1.22E-01 7.10E-02 4.10E-05 7.76E-03 
 
A - P-values of unscaled L, N, and PLmax values between the AI datasets to the normal GC and PBL controls.  B - P-values of PL and DLFSN values scaled 
by sequence alignment length in comparisons between the AI datasets to the normal GC and PBL controls.  C - P-values of L and OD values when scaled by 
tree pick size in comparisons between the AI datasets to the normal GC and PBL controls. D - P-values of unscaled DASN and DLSN values between the AI 
datasets to the normal GC and PBL controls. E - values of DASN and DLSN values when scaled by sequence alignment length between the AI datasets to the 
normal GC and PBL controls. Highlighted values were found to be significant after FDR correction. Tree properties and dataset identities described in the text 
and in Supplementary Table 1. 
 
